Methotrexate inhibits osteoclastogenesis by decreasing RANKL-induced calcium influx into osteoclast progenitors
Hiroya Kanagawa(Keio University), Takeshi Miyamoto(Kumamoto Health Science University), Yasuo Niki(Keio University), Ryuichi Watanabe(Keio University), Mayu Morita(Keio University), Hideo Morioka, Eri Katsuyama(Okayama University of Science), Hideyuki Saya(Fujita Health University Hospital), Ritsuko Masuyama(Ritsumeikan University), Hao Wu(Capital Medical University), Tami Kobayashi(Keio University), Atsuhiro Fujie(Keio University), Morio Matsumoto(Keio University Hospital), Toshimi Tando, Yoshiaki Toyama(Keio University), Yuiko Sato(Keio University), Kana Miyamoto(Kumamoto University)
Cited by 51
Related Papers
DC-STAMP is essential for cell–cell fusion in osteoclasts and foreign body giant cells
|The Journal of Experimental Medicine|2005|899
Bidirectional ephrinB2-EphB4 signaling controls bone homeostasis
|Cell Metabolism|2006|771
Commitment and Differentiation of Osteoclast Precursor Cells by the Sequential Expression of C-Fms and Receptor Activator of Nuclear Factor κb (Rank) Receptors
|The Journal of Experimental Medicine|1999|694
v-ATPase V0 subunit d2–deficient mice exhibit impaired osteoclast fusion and increased bone formation
|Nature Medicine|2006|542
Osteoclast Differentiation Factor (ODF) Induces Osteoclast-like Cell Formation in Human Peripheral Blood Mononuclear Cell Cultures
|Biochemical and Biophysical Research Communications|1998|344